Key Takeaways Johnson Controls shares led the S&P 500's gainers Wednesday morning after the company's first-quarter results ...

A judge has thrown out a felony indictment against a former Georgia prosecutor, ending her trial on charges that she abused ...

Lawyers claim Johnson & Johnson knew that the product contained cancer causing asbestos, but failed to warn customers and ...

Johnson Controls International named Joakim Weidemanis as chief executive officer and lifted its 2025 profit forecast on ...

Lumen Technologies, formerly CenturyLink, wants to be the trusted network for AI and has signed several multi-billion private ...

A collection of prominent healthcare interests were among the donors to President Donald Trump’s inaugural fund. | The pharma ...

New Brunswick, New Jersey-based Johnson & Johnson (JNJ) researches, develops, manufactures, and sells various products in the ...

Billionaire visionary, Bryan Johnson grabbed the headlines after he walked out of Nikhil Kamath's podcast, citing air ...

Dividend growth stocks offer a balance of stability and compounding returns, and here are three standout companies with ...

B Health and two safety-net hospitals want to help the government prove that drugmakers are required to give upfront ...

Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.

Guggenheim analyst Vamil Divan maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target of ...